These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22644068)

  • 21. Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
    Nel A; Bekker LG; Bukusi E; Hellstrӧm E; Kotze P; Louw C; Martinson F; Masenga G; Montgomery E; Ndaba N; van der Straten A; van Niekerk N; Woodsong C
    PLoS One; 2016; 11(3):e0147743. PubMed ID: 26963505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
    Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
    Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
    Bauermeister JA; Golinkoff JM; Carballo-Diéguez A; Giguere R; López D; Hoesley CJ; Chen BA; Anderson P; Dezzutti CS; Strizki J; Sprinkle C; Heard F; Hall W; Jacobson C; Berthiaume J; Mayo A; Richardson BA; Piper J;
    AIDS Behav; 2020 Feb; 24(2):607-616. PubMed ID: 30877580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    Atujuna M; Newman PA; Wallace M; Eluhu M; Rubincam C; Brown B; Bekker LG
    PLoS One; 2018; 13(2):e0191251. PubMed ID: 29420549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.
    van der Straten A; Panther L; Laborde N; Hoesley CJ; Cheng H; Husnik MJ; Horn S; Nel A; Soto-Torres L; Chen BA
    AIDS Behav; 2016 Nov; 20(11):2644-2653. PubMed ID: 26837628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability of the female condom among STD clinic patients.
    el-Bassel N; Krishnan SP; Schilling RF; Witte S; Gilbert L
    AIDS Educ Prev; 1998 Oct; 10(5):465-80. PubMed ID: 9799941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
    Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S
    BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
    Venables E; Stadler J
    Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
    Musara P; Milford C; Shapley-Quinn MK; Weinrib R; Mutero P; Odoom E; Mgodi NM; Chirenje ZM; Hanif H; Clark MR; Smit J; van der Straten A; Montgomery ET;
    AIDS Behav; 2021 Jan; 25(1):124-138. PubMed ID: 32588257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.
    Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
    AIDS Behav; 2015 May; 19(5):832-46. PubMed ID: 25488170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
    Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptability and use of a dapivirine vaginal ring in a phase III trial.
    Montgomery ET; van der Straten A; Chitukuta M; Reddy K; Woeber K; Atujuna M; Bekker LG; Etima J; Nakyanzi T; Mayo AJ; Katz A; Laborde N; Grossman CI; Soto-Torres L; Palanee-Phillips T; Baeten JM;
    AIDS; 2017 May; 31(8):1159-1167. PubMed ID: 28441175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: a mixed methods analysis.
    Robertson AM; Syvertsen JL; Martinez G; Rangel MG; Palinkas LA; Stockman JK; Ulibarri MD; Strathdee SA
    Glob Public Health; 2013; 8(5):619-33. PubMed ID: 23398385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial.
    Roberts ST; Hawley I; Luecke E; Mensch B; Wagner T; Hoesley C; McClure T; Dominguez Islas CP; Piper JM; Liu AY; van der Straten A
    J Womens Health (Larchmt); 2022 Jul; 31(7):1029-1039. PubMed ID: 34665672
    [No Abstract]   [Full Text] [Related]  

  • 36. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acceptability of the female condom among low-income African-American women.
    Shervington DO
    J Natl Med Assoc; 1993 May; 85(5):341-7. PubMed ID: 8496987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.
    Smith DJ; Wakasiaka S; Hoang TD; Bwayo JJ; Del Rio C; Priddy FH
    J Womens Health (Larchmt); 2008; 17(6):1025-34. PubMed ID: 18681822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.